Printer Friendly

Endo Closes Auxilium Pharmaceuticals Acquisition.


29 January 2015 - Irish drugmaker Endo International plc (NASDAQ: ENDP) (TSX: ENL) has completed the acquisition of US-based Auxilium Pharmaceuticals, Inc. in a transaction valued at USD 2.6bn when announced on 9 October 2014, the company said on Thursday.

The closing of the transaction follows the approval of the acquisition by Auxilium's shareholders on January 27, 2015, and the receipt of all required regulatory approvals.

According to Endo, the combined company will provide an expanded platform to accelerate the evolution and growth of Endo's US Branded Pharmaceuticals business.

With the acquisition complete, Endo's portfolio has a broader offering of urology and orthopedic products, it said.

Endo International develops, manufactures, markets, and distributes quality branded pharmaceutical, generic pharmaceutical, over the counter medications and medical device products through its operating companies. Endo has global headquarters in Dublin, Ireland, and US headquarters in Malvern, PA.

Country: USA

Sector: Pharmaceuticals

Target: Auxilium Pharmaceuticals, Inc

Buyer: Endo International plc

Deal size in USD: 2.6bn

Type: Corporate acquisition

Financing: Cash and Stock

Status: Closed

Buyer advisor: , ,


COPYRIGHT 2015 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M & A Navigator
Date:Jan 29, 2015
Previous Article:Emera Closes Sale of Northeast Wind Stake.
Next Article:II-VI to Merge Units.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters